Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
Sign Up to like & getrecommendations! Published in 2022 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-021-06700-0
Abstract: There has been a significant movement toward increasing the patient’s voice in assessment of tolerability of cancer treatments [1]. Traditional assessment of tolerability has relied on clinician-rated toxicities, using the National Cancer Institute’s Common Terminology… read more here.
Keywords: tolerability cancer; tolerability; patient; cancer treatments ... See more keywords
Safety and tolerability of cancer drugs studied in phase 3 randomized controlled trials (RCTs) over the last decade.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.6588
Abstract: 6588Background: Data suggest that newly approved cancer drugs have worse safety and tolerability profiles than older drugs used as control groups in trials. However, less is known about the toxicit... read more here.
Keywords: tolerability cancer; cancer drugs; safety tolerability;